Search research articles
Contact Us
Filters
Showing results (221-230 of 271) with videos related to
Page
of 28
Sort By:
Nature
|
May 3, 2019
CD8<sup>+</sup> T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang, Michael Green, Jae Eun Choi, et al.
Cancer Research
|
May 14, 2009
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
Sabine C Glöckner, Mashaal Dhir, Joo Mi Yi, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Nature Cancer
|
January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Nadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Cell
|
October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Antonio Omuro, Kathryn Beal, Philip Gutin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
Antonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Nature Communications
|
November 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Treg Grubb, Pooneh Koochaki, Sayed Matar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Holly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Genome Medicine
|
December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
Mahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 271) with videos related to
Sort By:
Page
of 28
Nature
|
May 3, 2019
CD8<sup>+</sup> T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang, Michael Green, Jae Eun Choi, et al.
Cancer Research
|
May 14, 2009
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
Sabine C Glöckner, Mashaal Dhir, Joo Mi Yi, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Nature Cancer
|
January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Nadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Cell
|
October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Antonio Omuro, Kathryn Beal, Philip Gutin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
Antonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Nature Communications
|
November 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Treg Grubb, Pooneh Koochaki, Sayed Matar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Holly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Genome Medicine
|
December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
Mahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Page
of 28